Copy
View this email in your browser
Twitter
Website
News Roundup
October 22, 2019
Updates from CLIC  
Insights to Inspire: Catapulting the Careers of Future Translational Scientists

Investing in the next generation is critically important in any industry, but it’s a particular focus within the field of translational science. The recent multi-year report from the Common Metrics Initiative highlights hubs that showed the most improvement in their careers metric. In this CLIC News article, those hubs share some advice that could help others strengthen their TL1 and KL2 award programs.

Click to Share
Click to Tweet
News from around the CTSA Program Consortium
Funding Opportunity for Myasthenia Gravis Researchers

The National Institutes of Health (NIH) awarded a research team from George Washington, Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis. The new Myasthenia Gravis Network (MGNet) will include basic and clinical investigators, patient advocacy groups, and biotechnology and pharmaceutical companies working together to enhance therapeutic development for this rare disease. To increase the number of labs researching myasthenia gravis and aid further discovery in the field, the grant will support a career enhancement program and a pilot program open to investigators at any academic institution across the country, so long as they have an MD, PhD, or equivalent.

Promotion and Tenure Policies for Team Science at Medical Institutions

Advancing understanding of human health promotion and disease prevention and treatment often requires teamwork. To evaluate academic medical institutions’ support for team science in the context of researchers’ career development, a team led by Penn State Clinical and Translational Science Institute's Susan McHale, Ph.D., measured the value placed on team science and specificity of guidance provided for documenting team science contributions in the promotion and tenure documents of Colleges/Schools of Medicine in the National Center for Advancing Translational Sciences’ Clinical and Translational Science Award program.

ICYMI: News from the Science & Research World
NPR: Scientists Create New, More Powerful Technique To Edit Genes

Scientists have created a new way to edit DNA that appears to make it even easier to precisely and safely re-write genes. The new technique, called prime editing, is designed to overcome some of the limitations of CRISPR. "If you think about CRISPR as flight — like a plane — then this new invention is kind of like a helicopter," says Fyodor Urnov, a geneticist at the University of California, Berkeley. "It also flies and gets you from point A to point B. But there are specific settings — like precisely landing at the top of the Salesforce tower here in San Francisco — where you could imagine that a helicopter would be better than a plane."

Click to Share
Click to Tweet
If you have a story, opportunity, project or event that you'd like included in the News Roundup, please contact CLIC Communications: clic_comms@clic-ctsa.org.

The University of Rochester Center for Leading Innovation and Collaboration (CLIC) is the coordinating center for the Clinical and Translational Science Awards (CTSA) Program, funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), Grant U24TR002260.

 
Twitter
Website
Copyright © 2019 University of Rochester - CLIC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.